Abstract:CRISPR systems have been proven as versatile tools for site-specific genome engineering in mammalian species. During the gene editing processes, these RNA-guide nucleases introduce DNA double strand breaks (DSBs), in which non-homologous DNA end joining (NHEJ) dominates the DNA repair pathway, limiting the efficiency of homology-directed repair (HDR), the alternative pathway essential for precise gene targeting. Multiple approaches have been developed to enhance HDR, including chemical compound or RNA interference-mediated inhibition of NHEJ factors, small molecule activation of HDR enzymes, or cell cycle timed delivery of CRISPR complex. However, these approaches face multiple challenges, yet have moderate or variable effects. Here we developed a new approach that programs both NHEJ and HDR pathways with CRISPR activation and interference (CRISPRa/i) to achieve significantly enhanced HDR efficiency of CRISPR-mediated gene editing. The manipulation of NHEJ and HDR pathway components, such as CtIP, CDK1, KU70, KU80, and LIG4, was mediated by catalytically dead guide RNAs (dgRNAs), thus relying on only a single catalytically active Cas9 to perform both CRISPRa/i and precise gene editing. While reprogramming of most DNA repair factors or their combinations tested enhanced HDR efficiency, simultaneously activating CDK1 and repressing KU80 has the strongest effect with increased HDR rate upto an order of magnitude. Doxycycline-induced dgRNA-based CRISPRa/i programming of DNA repair enzymes, as well as viral packaging enabled flexible and tunable HDR enhancement for broader applicability in mammalian cells. Our study provides an effective, flexible, and potentially safer strategy to enhance precise genome modifications, which might broadly impact human gene editing and therapy.

Engineering the Direct Repeat Sequence of Crrna for Optimization of FnCpf1-Mediated Genome Editing in Human Cells

A 'new Lease of Life': FnCpf1 Possesses DNA Cleavage Activity for Genome Editing in Human Cells

A Single Multiplex Crrna Array for FnCpf1-Mediated Human Genome Editing.

SgRNA Engineering for Improved Genome Editing and Expanded Functional Assays.

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Engineering CRISPR–Cpf1 Crrnas and Mrnas to Maximize Genome Editing Efficiency

Optimizing a CRISPR-Cpf1-based genome engineering system for Corynebacterium glutamicum

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Development and application of CRISPR/Cas9 technologies in genomic editing.

Engineered DNase-inactive Cpf1 Variants to Improve Targeting Scope for Base Editing in E. Coli

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

PAM-Flexible Genome Editing with an Engineered Chimeric Cas9.

Functional Non-Homologous End Joining Patterns Triggered by CRISPR/Cas9 in Human Cells.

Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems

FnCpf1: a novel and efficient genome editing tool for Saccharomyces cerevisiae

Base Editing with a Cpf1–cytidine Deaminase Fusion

[The new generation tool for CRISPR genome editing: CRISPR/Cpf1].

PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics

The Development of a CRISPR-FnCpf1 System for Large-Fragment Deletion and Multiplex Gene Editing in Acinetobacter baumannii

The crystal structure of Cpf1 in complex with CRISPR RNA

Cpf1 Proteins Excise CRISPR RNAs from Mrna Transcripts in Mammalian Cells